Arthritis Market Next Big Thing 2026 | AbbVie Inc., Pfizer Inc., Amgen Inc., Johnson & Johnson Services Inc, Gilead Sciences, Inc., Eli Lilly and Company, Novartis AG, Sanofi

Global arthritis market is expected to register a substantial CAGR in the forecast period of 2019-2026. The report contains data from the base year of 2018 and the historic year of 2017. This rise in market value can be attributed to the increasing awareness regarding the disease and the modes of its treatment.Global Arthritis Market By Rheumatoid Drug Type (Biologics, Non-Biologics, Steroids, Analgesics, Glucocorticoids, Others), Rheumatoid Diagnosis (CRP Test, CCP, ESR Test), Rheumatoid Treatment (Synovectomy, Tendon Repair, Joint Fusion, Symptomatic Treatment, Intermediate Corticosteroid Therapies, DMARD Therapies), Osteoarthritis Type (Hip, Spinal, Knee, Foot & Ankle, Shoulder, Hand), Osteoarthritis Diagnosis (Imaging, Joint Fluid Analysis, Others), Osteoarthritis Treatment (Medication, Drugs, Assistive Devices, Surgery, Therapy), Route of Administration (Oral, Parenteral), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Drug Stores), End-Users (Hospitals, Clinics, Household, Medical Institutes, Research Organizations, Others), Geography (North America, Europe, Asia-Pacific, South America, Middle East and Africa) - Industry Trends and Forecast to 2026.

Complete study compiled with over 100+ pages, list of tables & figures, profiling 10+ companies. Ask for Sample @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-arthritis-market&skp

Key Market Competitors:

Few of the major competitors currently working in the global arthritis market are AbbVie Inc., Pfizer Inc., Amgen Inc., Johnson & Johnson Services, Inc., CELGENE CORPORATION, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, UCB S.A., Gilead Sciences, Inc., Eli Lilly and Company, Novartis AG, Sanofi, AstraZeneca, Astellas Pharma Inc., Galapagos NV, Taisho Pharmaceutical Holdings Co., Ltd., Boehringer Ingelheim GmbH, Swedish Orphan Biovitrum AB (publ), Regeneron Pharmaceuticals, Abiogen Pharma Spa, Merck & Co., Inc., Kolon TissueGene, Inc., Ampio Pharmaceuticals Inc., GlaxoSmithKline plc among others.

Arthritis, also known as inflammation of joints is described as the tenderness or swelling occurring in the joints of patients, with the symptoms of the disease being stiffness and pain in joints. It is categorized into two most common variants as rheumatoid arthritis and osteoarthritis. The patient suffers from significant lack of motion.

Market Drivers

o Rising cases of rheumatoid arthritis worldwide will accelerate the market growth
o Increasing aging population is another factor uplifting the market growth
o Growing demand for minimally invasive procedures among population will also enhance the market growth
o Increasing obesity among population also acts as market driver in the forecast period

Market Restraints

o Increasing risk of side effects associated with treatment of arthritis will restrain the market growth
o High cost of hyaluronic acid products will hinder the growth of the market
o Lack of effective treatment other than symptomatic mode for osteoarthritis also acts as a market restraint

Segmentation: Global Arthritis Market

By Rheumatoid Drug Type

o Biologics
o Non-Biologics
o Steroids
o Analgesics
o Glucocorticoids
o Others

By Rheumatoid Diagnosis

o C-Reactive Protein (CRP) Test
o Cyclic Citrullinated Peptide (CCP)
o Erythrocyte Sedimentation Rate (ESR) Test

By Rheumatoid Treatment

o Synovectomy
o Tendon Repair
o Joint Fusion
o Symptomatic Treatment
o Intermediate Corticosteroid Therapies
o Disease-Modifying Anti-Rheumatic Drug (DMARD) Therapies

By Osteoarthritis Type

o Hip
o Spinal
o Knee
o Foot & Ankle
o Shoulder
o Hand

By Osteoarthritis Diagnosis

o Imaging
o Joint Fluid Analysis
o Others

By Osteoarthritis Treatment

o Medication
o Drugs
o Assistive Devices
o Surgery
o Therapy

By Route of Administration

o Oral
o Parenteral

By Distribution Channel

o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy
o Drug Stores

By End-Users

o Hospitals
o Clinics
o Household
o Medical Institutes
o Research Organizations
o Others

Key Developments in the Market:

o In October 2019, Gilead Sciences, Inc. announced that they had submitted a new drug application (NDA) for their investigational, oral, selective JAK 1 inhibitor, "filgotinib" for treatment of adults suffering from rheumatoid arthritis to the Japanese Ministry of Health, Labour and Welfare (MHLW). This application will enable the company to enhance their presence in the region for providing therapeutics for inflammation
o In August 2019, AbbVie announced that they had received U.S. FDA approval for "RINVIQ (upadacitinib)", once-daily 15 mg oral Janus Kinase (JAK) inhibitor designed for the treatment of adults suffering from moderate to severe range of rheumatoid arthritis having an inadequate response to methotrexate (MTX-IR). The drug will be available from late August, 2019

Competitive Analysis:

Global arthritis market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of arthritis market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Table of Content: Global Arthritis Market :-

Part 01: Executive Summary

Part 02: Scope of The Report

Part 03: Global Arthritis Market Landscape

Part 04: Global Arthritis Market Sizing

Part 05: Global Arthritis Market Segmentation by Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Continue....

Table Of Contents Is Available Here@ https://www.databridgemarketresearch.com/toc/?dbmr=global-arthritis-market&skp

Report Highlights : Arthritis Market

Detailed overview of parent market (Arthritis Market)

Market dynamics in the Arthritis market

In-depth Arthritis market segmentation

Historical, current, and projected Arthritis market size in terms of volume and value

Recent industry trends and developments in the global Arthritis market

Competitive landscape

Strategies of key players and products offered in the global Arthritis market

Potential and niche segments, geographical regions exhibiting promising growth

A neutral perspective on Arthritis market performance

Must-have information for market players in Arthritis market to sustain and enhance their market footprint.

Reasons to Purchase this Arthritis Market Report:

Current and future of global Arthritis market outlook in the developed and emerging markets

The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

Regions/Countries that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

For More Information or Query or Customization before Buying, Visit @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-arthritis-market&skp

Key questions answered
Who are the Leading key players and what are their Key Business plans in the Global Arthritis market?
What are the key concerns of the five forces analysis of the Global Arthritis market?
What are different prospects and threats faced by the dealers in the Global Arthritis market?
What are the strengths and weaknesses of the key vendors?

Contact Us:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email:Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research:

Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.